WHAT YOU SHOULD KNOW
These are not all the risks & side effects of APRETUDE, and this information does not replace talking with your doctor about your medical conditions or treatment. For more information, talk to your doctor and refer to the Patient Information for APRETUDE.
What is the most important information I should know about APRETUDE?
Important information for people who receive APRETUDE to help reduce their risk of getting human immunodeficiency virus-1 (HIV-1) infection, also called pre-exposure prophylaxis or “PrEP”:
Before receiving APRETUDE to reduce your risk of getting HIV-1:
You must be HIV-1 negative to start APRETUDE. You must get tested to make sure that you do not already have HIV-1 infection
Do not receive APRETUDE for HIV-1 PrEP unless you are confirmed to be HIV-1 negative
Some HIV-1 tests can miss HIV-1 infection in a person who has recently become infected. If you have flu-like symptoms, you could have recently become infected with HIV-1. Tell your healthcare provider if you had a flu-like illness within the last month before starting APRETUDE or at any time while receiving APRETUDE. Symptoms of new HIV-1 infection include:
joint or muscle aches
enlarged lymph nodes in the neck or groin
vomiting or diarrhea
While you are receiving APRETUDE for HIV-1 PrEP:
APRETUDE does not prevent other sexually transmitted infections. Practice safer sex by using a latex or polyurethane condom to reduce the risk of getting sexually transmitted infections
You must stay HIV-1 negative to keep receiving APRETUDE for HIV-1 PrEP
Know your HIV-1 status and the HIV-1 status of your partners
Ask your partners with HIV-1 if they are taking anti-HIV-1 medicines and have an undetectable viral load. An undetectable viral load is when the amount of virus in the blood is too low to be measured in a lab test. To maintain an undetectable viral load, your partners must keep taking HIV-1 medicine as prescribed. Your risk of getting HIV-1 is lower if your partners with HIV-1 are taking effective treatment
Get tested for HIV-1 with each APRETUDE injection or when your healthcare provider tells you. You should not miss any HIV-1 tests. If you become HIV-1 infected and continue receiving APRETUDE because you do not know you are HIV-1 infected, the HIV-1 infection may become harder to treat
Get tested for other sexually transmitted infections such as syphilis, chlamydia, and gonorrhea. These infections make it easier for HIV-1 to infect you
If you think you were exposed to HIV-1, tell your healthcare provider right away. They may want to do more tests to be sure you are still HIV-1 negative
Get information and support to help reduce sexual risk behaviors
Do not miss any injections of APRETUDE. Missing injections increases your risk of getting HIV-1 infection
If you do become HIV-1 positive, you will need to take other medicines to treat HIV-1. APRETUDE is not approved for treatment of HIV-1
If you have HIV-1 and receive only APRETUDE, over time your HIV-1 may become harder to treat.
Who should not receive APRETUDE?
Do not receive APRETUDE if you:
already have HIV-1 infection. If you are HIV-1 positive, you will need to take other medicines to treat HIV-1. APRETUDE is not approved for treatment of HIV-1
do not know your HIV-1 infection status. You may already be HIV-1 positive. You need to take other medicines to treat HIV-1. APRETUDE can only help reduce your risk of getting HIV-1 infection before you are infected
are allergic to cabotegravir
are taking any of the following medicines:
What are the possible side effects of APRETUDE?
APRETUDE may cause serious side effects including:
Allergic reactions. Call your healthcare provider right away if you develop a rash with APRETUDE. Stop receiving APRETUDE and get medical help right away if you develop a rash with any of the following signs or symptoms:
generally ill feeling
muscle or joint aches
blisters or sores in mouth
redness or swelling of the eyes
swelling of the mouth, face, lips, or tongue
Liver problems. Liver problems have happened in people with or without a history of liver problems or other risk factors. Your healthcare provider may do blood tests to check your liver function.
Call your healthcare provider right away if you develop any of the following signs or symptoms of liver problems:
your skin or the white part of your eyes turns yellow (jaundice)
dark or "tea-colored" urine
light-colored stools (bowel movements)
nausea or vomiting
loss of appetite
pain, aching, or tenderness on the right side of your stomach area
Depression or mood changes. Call your healthcare provider or get medical help right away if you have any of the following symptoms:
feeling sad or hopeless
feeling anxious or restless
have thoughts of hurting yourself (suicide) or have tried to hurt yourself
The most common side effects of APRETUDE include:
pain, tenderness, hardened mass or lump, swelling, bruising, redness, itching, warmth, loss of sensation at the injection site, abscess, and discoloration
loss of appetite
upper respiratory infection
These are not all the possible side effects of APRETUDE.
Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Please read the Patient Information for APRETUDE and discuss it with your healthcare provider.
Before receiving APRETUDE, tell your healthcare provider about all your medical conditions, including if you:
have ever had a skin rash or an allergic reaction to medicines that contain cabotegravir
have or have had liver problems
have ever had mental health problems
are pregnant or plan to become pregnant. It is not known if APRETUDE will harm your unborn baby. APRETUDE can remain in your body for up to 12 months or longer after the last injection. Tell your healthcare provider if you become pregnant while receiving APRETUDE. Pregnancy Registry. There is a pregnancy registry for women who receive APRETUDE during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry
are breastfeeding or plan to breastfeed. It is not known if APRETUDE can pass to your baby in your breast milk. Talk with your healthcare provider about the best way to feed your baby while receiving APRETUDE
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Some medicines may interact with APRETUDE. Keep a list of your medicines and show it to your healthcare provider and pharmacist when you get a new medicine.
You can ask your healthcare provider or pharmacist for a list of medicines that interact with APRETUDE.
Do not start a new medicine without telling your healthcare provider. Your healthcare provider can tell you if it is safe to receive APRETUDE with other medicines.
How will I receive APRETUDE?
APRETUDE is initially given as an injection into the muscle of your buttock 1 time every month for the first 2 months, then as an injection 1 time every 2 months
Before receiving your first injection dose of APRETUDE, your healthcare provider may have you take 1 oral cabotegravir tablet 1 time a day for 1 month (at least 28 days.) This will allow your healthcare provider to assess how well you will tolerate cabotegravir
APRETUDE is a long-acting medicine and may stay in your body for 12 months or longer after your last injection
Stay under the care of a healthcare provider while receiving APRETUDE. It is important that you receive APRETUDE as scheduled
If you miss or plan to miss a scheduled injection of APRETUDE by more than 7 days, call your healthcare provider right away to discuss your PrEP options
If you stop receiving APRETUDE, talk to your healthcare provider about other options to reduce the risk of getting HIV-1 infection